China Pharma Holdings (CPHI) Operating Expenses (2010 - 2026)

China Pharma Holdings has reported Operating Expenses for 17 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 125.32% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.9 million (up 49.53% YoY), and the FY2025 full-year result was $3.1 million, up 19.36% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.4 million, up from $1.4 million in the prior quarter.
• The five-year high for Operating Expenses was $1.4 million in Q1 2026, with the low at $309647.0 in Q2 2023.
• Historically, Operating Expenses has averaged $743464.3 across 5 years, with a median of $575403.0 in 2023.
• Annual changes were most pronounced in 2023 — Operating Expenses plunged 43.72% — and 2026, when it soared 125.32%.
• China Pharma Holdings' Operating Expenses stood at $1.2 million in 2022, then slipped by 8.78% to $1.1 million in 2023, then fell by 6.32% to $1.0 million in 2024, then surged by 30.47% to $1.4 million in 2025, then climbed by 3.83% to $1.4 million in 2026.
• The last three Operating Expenses figures came in at $1.4 million (Q1 2026), $1.4 million (Q4 2025), and $568491.0 (Q3 2025), per Business Quant data.